Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of Victoria

$25,000.00

Molecular characterization of SSI products from Qu biologics

EF 2018-19

Résumé
Site-Specific Immunomodulators (SSIs) are a first-in class immunotherapy platform derived from specific*inactivated microbial strains developed by Qu Biologics. SSIs are designed to restore the body's normal*immune function in a targeted tissue or organ site to treat immune-related diseases, such as Crohn's Diseases*and various forms of cancer. Given SSIs are a complex mixture of many different biomolecules such as*proteins and metabolites, there are challenges in demonstrating a standardized manufacturing process between*batches of the product. This project will use various untargeted mass spectrometry techniques to investigate the*complement of different proteins and metabolites present in different SSI products. By comparing the*molecular profiles between active and inactive batches, we will investigate whether a biological ""fingerprint""*can be determined, specific to the functional form of different SSI products; the goal being to use the derived*fingerprint to demonstrate batch to batch equivalency. The company will benefit by having molecular profiles*that can be used to generate assays to support the standardization of their manufacturing process and eventually*be used to facilitate the regulatory approval of their products.*Other Language Version of Summary (optional).*Valid 319459 Borchers*Form 101
Programme
Engage Grants Program
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
528557-2018
Name nom
Borchers, Christoph
Department département
Biochemistry and Microbiology
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5403
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Proteins and peptides, amino acids
Research subject fr
Protéines et peptides, acides aminés
Partie
1
Nb partie
1
Application title
Molecular characterization of SSI products from Qu biologics
Keyword
NSERC
Application summary
Site-Specific Immunomodulators (SSIs) are a first-in class immunotherapy platform derived from specific*inactivated microbial strains developed by Qu Biologics. SSIs are designed to restore the body's normal*immune function in a targeted tissue or organ site to treat immune-related diseases, such as Crohn's Diseases*and various forms of cancer. Given SSIs are a complex mixture of many different biomolecules such as*proteins and metabolites, there are challenges in demonstrating a standardized manufacturing process between*batches of the product. This project will use various untargeted mass spectrometry techniques to investigate the*complement of different proteins and metabolites present in different SSI products. By comparing the*molecular profiles between active and inactive batches, we will investigate whether a biological ""fingerprint""*can be determined, specific to the functional form of different SSI products; the goal being to use the derived*fingerprint to demonstrate batch to batch equivalency. The company will benefit by having molecular profiles*that can be used to generate assays to support the standardization of their manufacturing process and eventually*be used to facilitate the regulatory approval of their products.*Other Language Version of Summary (optional).*Valid 319459 Borchers*Form 101